4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-057936
Director sold 10,000 shares at $60.03 ($600,310)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Director | 2020-11-10 | Sale | −10,000 | $60.03 | $600,310 | 55,000 | D |
| Open-market sales · 10,000 sh · avg $60.03 · $600,310 | |||||||
Loading xslF345X03/doc4.xml…